Amedisys Inc (NAS:AMED)
$ 94.95 -0.54 (-0.57%) Market Cap: 3.10 Bil Enterprise Value: 3.49 Bil PE Ratio: 0 PB Ratio: 2.85 GF Score: 85/100

Amedisys Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 16, 2022 / 02:40PM GMT
Release Date Price: $156.84 (+3.44%)
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Good morning. Welcome to Day 2 of Oppenheimer's Annual Healthcare Conference. My name is Michael Wiederhorn. I'm the health care services analyst. Today, we are hosting Amedisys. We have Chris Gerard, COO and incoming CEO; Scott Ginn, Chief Financial Officer; and Nick Muscato, Senior VP of Finance. We'll be doing the fire side. We also, for the audience, there should be a Q&A portal in the top right corner of your screen that you can submit questions into. Feel free to use that at any time.

So welcome. Thanks, guys, for joining me virtually here. Hopefully, next year, we'll be back in person.

Questions & Answers

Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

But I'll start right here with kind of a high-level question. If you kind of just give me an update or just discuss what you're seeing in terms of trends post the Omicron peak? Kind of give us an update there, start with that.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot